International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released May 15, 2017, after the close
10-Q filed May 15, 2017, 45 days after period end · 0001564590-17-011040
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $2.01M | $1.62M | $1.62M | $1.65M |
| Net Income | -$3.08M | -$14.57M | -$1.29M | -$1.44M |
| EPS Diluted | -$0.78 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$5.19 |
| -$1.07 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
